Prospective Multicenter Evaluation of a New Short-access-cholangioscope

Status Completed

Clinical Trial Summary

Karl Storz GmbH (Gesellschaft mit beschränkter Haftung) company developed a cholangioscopic device, which is designed to give a better flexibility to the cholangioscopy tip in order to enable optimal diagnostic and therapeutic precondition. Other than the conventional mother-baby technique, the insertion of the cholangioscope (baby part) is done by a port at the side of a specially developed duodenoscope (mother part) which is prepositioned distally to the control unit, near to the patient's mouth. Better manoeuverability of the device tip will lead to both a better accuracy in taking biopsies as well as a better flexibility in lithotripsy manoeuvres. This study is designed to test the efficiency of the device in relation to this assumption.

Clinical Trial Description

Cholangioscopy is a subsidiary treatment in endoscopic retrograde cholangiopancreaticography (ERCP), used for special issues. In the context of ERCP, a long,thin shaped device is introduced through the working channel of a duodenoscope and then through the papilla into the biliary duct.

Inspection of the biliary duct can be used for tumor biopsies as well as for gall stone lithotripsy by laser or electrohydraulic technique.

Manoeuverability of cholangioscopes is limited by the length of the scope, even more, since most of the device body is stuck in the working channel.

The newly designed cholangioscope by the company of Karl Storz GmbH is introduced through a shortened working channel. Introduction of the cholangioscope is done by an innovative side port for the cholangioscope at 70 cm from the insertion tube's distal end. This leads to a better flexibility of the device tip. Better manoeuverability of the device tip will lead to both a better accuracy in taking biopsies as well as a better flexibility in lithotripsy manoeuvres.

This study is designed to test the efficiency of the device in relation to this assumption. ;

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01683240
Study type	Interventional
Source	Universitätsklinikum Hamburg-Eppendorf
Contact
Status	Completed
Phase	N/A
Start date	February 2011
Completion date	February 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03536247` - Papillary Balloon Dilation Versus Intraductal Lithotripsy	N/A
Recruiting	`NCT05035433` - Effect of the Sequence of Dilatation and Lithotripsy on the Treatment of Choledocholithiasis With ERCP	N/A
Not yet recruiting	`NCT06060002` - Role of Prophylactic Biliary Stent in Reducing the Recurrence of Choledocholithiasis	N/A
Recruiting	`NCT06041113` - Recurrent Extrahepatic Bile Duct Stones as a Late Complication of ERCP in Patients With Coexisting Intra- and Extrahepatic Bile Duct Stones
Completed	`NCT02461147` - Prospective Validation of "Cholecystectomy First" Strategy for Gallstone Migration
Recruiting	`NCT00416234` - Laparoendoscopic Rendez Vous Versus Standard Two Stage Approach for the Management of Cholelithiasis/Choledocholithiasis	N/A
Active, not recruiting	`NCT05592795` - Explore the Effects and Mechanisms of ERCP and EST on Biliary Microecology
Recruiting	`NCT05056506` - EPLBD With Limited EST vs. EPLBD for Choledocholithiasis	N/A
Completed	`NCT02515474` - Comparison of LCBDE vs ERCP + LC for Choledocholithiasis	N/A
Recruiting	`NCT05429203` - Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope	N/A
Completed	`NCT01824186` - Trial Comparing Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy	N/A
Completed	`NCT02647593` - The Clinical Characteristics of the Patients With Choledocholithiasis Without Cholangitis
Not yet recruiting	`NCT06066372` - Application of Machine Learning Models to Reduce Need for Diagnostic EUS or MRCP in Patients With Intermediate Likelihood of Choledocholithiasis
Completed	`NCT04716166` - Incentive Spirometry and Upper Abdominal Laparoscopic Surgery	N/A
Completed	`NCT03074201` - Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP	N/A
Withdrawn	`NCT01475864` - Prospective Evaluation of the Covered Self-expandable Metal Stents (CSEMS) for Incomplete Biliary Stone Clearance	N/A
Recruiting	`NCT06265311` - IDUS in CBD Stone Recurrence High Risk Patients	N/A
Completed	`NCT02870686` - EUS Guided ERCP in Bile Duct Stone Removal	N/A
Recruiting	`NCT05611840` - RCT on Robotic vs. Endo-laparoscopic Approach for Difficult Choledocholithiasis	N/A
Recruiting	`NCT03102281` - Microbiomes in Patients of Recurrent Common Bile Duct Stones	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones — SAC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms